spacer
spacer

PDBsum entry 1w5r

Go to PDB code: 
protein Protein-protein interface(s) links
Transferase PDB id
1w5r

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
273 a.a. *
Waters ×398
* Residue conservation analysis
PDB id:
1w5r
Name: Transferase
Title: X-ray crystallographic structure of a c70q mycobacterium smegmatis n- arylamine acetyltransferase
Structure: Arylamine n-acetyltransferase. Chain: a, b. Engineered: yes. Mutation: yes
Source: Mycobacterium smegmatis. Organism_taxid: 1772. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
1.45Å     R-factor:   0.197     R-free:   0.220
Authors: S.J.Holton,J.Sandy,F.Rodrigues-Lima,J.-M.Dupret,S.Bhakta,M.E.M.Noble, E.Sim
Key ref: J.Sandy et al. (2005). Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines. Biochem J, 390, 115-123. PubMed id: 15869465
Date:
09-Aug-04     Release date:   11-May-05    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
O86309  (NAT_MYCSM) -  Arylamine N-acetyltransferase from Mycolicibacterium smegmatis
Seq:
Struc:
275 a.a.
273 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.2.3.1.5  - arylamine N-acetyltransferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: an arylamine + acetyl-CoA = an N-acetylarylamine + CoA
arylamine
+ acetyl-CoA
= N-acetylarylamine
+ CoA
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
Biochem J 390:115-123 (2005)
PubMed id: 15869465  
 
 
Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines.
J.Sandy, A.Mushtaq, S.J.Holton, P.Schartau, M.E.Noble, E.Sim.
 
  ABSTRACT  
 
The NATs (arylamine N-acetyltransferases) are a well documented family of enzymes found in both prokaryotes and eukaryotes. NATs are responsible for the acetylation of a range of arylamine, arylhydrazine and hydrazine compounds. We present here an investigation into the catalytic triad of residues (Cys-His-Asp) and other structural features of NATs using a variety of methods, including site-directed mutagenesis, X-ray crystallography and bioinformatics analysis, in order to investigate whether each of the residues of the catalytic triad is essential for catalytic activity. The catalytic triad of residues, Cys-His-Asp, is a well defined motif present in several families of enzymes. We mutated each of the catalytic residues in turn to investigate the role they play in catalysis. We also mutated a key residue, Gly126, implicated in acetyl-CoA binding, to examine the effects on acetylation activity. In addition, we have solved the structure of a C70Q mutant of Mycobacterium smegmatis NAT to a resolution of 1.45 A (where 1 A=0.1 nm). This structure confirms that the mutated protein is correctly folded, and provides a structural model for an acetylated NAT intermediate. Our bioinformatics investigation analysed the extent of sequence conservation between all eukaryotic and prokaryotic NAT enzymes for which sequence data are available. This revealed several new sequences, not yet reported, of NAT paralogues. Together, these studies have provided insight into the fundamental core of NAT enzymes, and the regions where sequence differences account for the functional diversity of this family. We have confirmed that each of the three residues of the triad is essential for acetylation activity.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
19379125 D.W.Hein (2009).
N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine.
  Expert Opin Drug Metab Toxicol, 5, 353-366.  
19860825 X.Zhou, N.Zhang, L.Liu, K.J.Walters, P.E.Hanna, and C.R.Wagner (2009).
Probing the catalytic potential of the hamster arylamine N-acetyltransferase 2 catalytic triad by site-directed mutagenesis of the proximal conserved residue, Tyr190.
  FEBS J, 276, 6928-6941.  
18795795 A.L.Sikora, B.A.Frankel, and J.S.Blanchard (2008).
Kinetic and chemical mechanism of arylamine N-acetyltransferase from Mycobacterium tuberculosis.
  Biochemistry, 47, 10781-10789.  
18680471 E.Sim, J.Sandy, D.Evangelopoulos, E.Fullam, S.Bhakta, I.Westwood, A.Krylova, N.Lack, and M.Noble (2008).
Arylamine N-acetyltransferases in mycobacteria.
  Curr Drug Metab, 9, 510-519.  
18680467 J.M.Walraven, Y.Zang, J.O.Trent, and D.W.Hein (2008).
Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.
  Curr Drug Metab, 9, 471-486.  
17374145 I.M.Westwood, and E.Sim (2007).
Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa.
  BMC Biochem, 8, 3.  
17434923 Y.Zang, M.A.Doll, S.Zhao, J.C.States, and D.W.Hein (2007).
Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2.
  Carcinogenesis, 28, 1665-1671.  
17264801 Y.Zang, S.Zhao, M.A.Doll, J.Christopher States, and D.W.Hein (2007).
Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2.
  Pharmacogenet Genomics, 17, 37-45.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer